Evidence map›Paper›PMID 23708250›Full record

ArticleNature immunology2013

A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells.

Eric L Fritz, Brad R Rosenberg, Kenneth Lay, Aleksandra Mihailović, Thomas Tuschl, F Nina Papavasiliou

Abstract read
In one paragraph

Article in Nature immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Defining chromosomal translocation risks in cancer.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eric L FritzLaboratory of Lymphocyte Biology, The Rockefeller University, New York, New York, USA. efritz@rockefeller.edu
Brad R Rosenberg
Kenneth Lay
Aleksandra Mihailović
Thomas Tuschl
F Nina Papavasiliou

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
The Regulation of Somatic HypermutationR01CA098495 · NCI · ROCKEFELLER UNIVERSITY · PI PAPAVASILIOU, F. NINA · 2003 to 2012
$2.5M
Howard Hughes Medical InstituteNCI NIH HHS CA098495NCI NIH HHS R01 CA098495NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Beyond its well-characterized functions in antibody diversification, the cytidine deaminase AID can catalyze off-target DNA damage and has been hypothesized to edit RNA and mediate DNA demethylation. To comprehensively examine the effects of AID on the transcriptome and the pattern of DNA methylation ('methylome'), we analyzed AID-deficient (Aicda(-/-)), wild-type and AID-overexpressing activated B cells by high-throughput RNA sequencing (RNA-Seq) and reduced-representation bisulfite sequencing (RRBS). These analyses confirmed the known role of AID in immunoglobulin isotype switching and also demonstrated few other effects of AID on gene expression. Additionally, we detected no evidence of AID-dependent editing of mRNA or microRNA. Finally, the RRBS data did not support the proposed role for AID in regulating DNA methylation. Thus, despite evidence of its additional activities in other systems, antibody diversification seems to be the sole physiological function of AID in activated B cells.

Indexed as

AnimalsB-LymphocytesCytidine DeaminaseFemaleImmunoglobulin IsotypesMaleMiceMice, KnockoutMicroRNAsRNA, MessengerSequence Analysis, DNASomatic Hypermutation, ImmunoglobulinTranscriptomeCytidine DeaminaseImmunoglobulin IsotypesMicroRNAsRNA, Messenger

Identifiers

PMID23708250
PMCPMC3688651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.